We enjoyed speaking to Carl Regillo (Wills Eye Hospital, Philadelphia, PA, USA) about incidence and prognosis of geographic atrophy, and advances in understanding of genetics and pathophysiology of dry AMD.
- Could you give us a brief overview of geographic atrophy, its incidence and prognosis? (00:17)
- Why have we failed to achieve the same breakthroughs in the treatment of dry age-related macular degeneration (AMD) as that of wet AMD? (02:11)
- What advances have been made in our understanding of the genetics and pathophysiology of dry AMD? (03:28)
Speaker Disclosure: Carl Regillo has no financial or non-financial relationships or activities to declare in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of Hawaiian Eye and Retina 2021.
Share this Video
Related Videos In Macular Degeneration
Kyoko Ohno-Matsui, EURETINA 2021: Advantages and Limitations of a Deep Learning Algorithm
We were delighted to speak with Kyoko Ohno-Matsui (Tokyo Medical and Dental University, Tokyo, Japan) about the potential advantages and limitations of a deep learning algorithm for automated detection of myopic maculopathy and pathologic myopia in fundus images, and the challenges in developing this algorithm. Questions What are the potential advantages and limitations of a […]
Kyoko Ohno-Matsui, EURETINA 2021: Results of a Study Evaluating a Deep Learning Algorithm
It was a pleasure to catch up with Kyoko Ohno-Matsui (Tokyo Medical and Dental University, Tokyo, Japan), who discussed the results of her study evaluating a deep learning algorithm for automated detection of myopic maculopathy and pathologic myopia in fundus images. Questions What were the methodology and outcome measures of your study evaluating a deep […]
Carl Regillo, Hawaiian Eye and Retina 2021: Geographic Atrophy – Current Therapeutic Approaches and Future Prospects
It was a pleasure to catch up with Carl Regillo (Wills Eye Hospital, Philadelphia, PA, USA), who talked us through the therapeutic approaches currently in clinical trial investigation for the treatment of geographic atrophy, and his views on exciting future prospects for treatment. Questions Could you give us a brief overview of the therapeutic approaches […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!